Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cadherin-4 (CDH4), also known as R-cadherin or retinal cadherin, is a classical cadherin from the cadherin superfamily and encodes a calcium-dependent cell-cell adhesion glycoprotein composed of five extracellular cadherin repeats, a transmembrane region, and a highly conserved cytoplasmic tail. CDH4 mediates homophilic and heterophilic interactions at cell-cell junctions, playing critical roles in neural development, brain segmentation, neuronal outgrowth, and the organization of retinal, kidney, and muscle tissues. It has been implicated in various pathological conditions, including cancer metastasis and certain congenital and developmental disorders. Although it is important in development and disease, no approved drugs are currently known to directly target Cadherin-4[1][2][3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cadherin-4 (CDH4).